The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function

被引:7
作者
Kramer, Andreas [1 ]
Billaud, Jean-Noel [1 ]
Tugendreich, Stuart [1 ]
Shiffman, Dan [1 ]
Jones, Martin [1 ]
Green, Jeff [1 ]
机构
[1] QIAGEN, Digital Insights, Redwood City, CA 94063 USA
关键词
COVID-19; Knowledge graph; Drug repurposing; Network biology; COVID-19; GENES;
D O I
10.1186/s12859-021-04148-x
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Leveraging previously identified viral interactions with human host proteins, we apply a machine learning-based approach to connect SARS-CoV-2 viral proteins to relevant host biological functions, diseases, and pathways in a large-scale knowledge graph derived from the biomedical literature. Our goal is to explore how SARS-CoV-2 could interfere with various host cell functions, and to identify drug targets amongst the host genes that could potentially be modulated against COVID-19 by repurposing existing drugs. The machine learning model employed here involves gene embeddings that leverage causal gene expression signatures curated from literature. In contrast to other network-based approaches for drug repurposing, our approach explicitly takes the direction of effects into account, distinguishing between activation and inhibition. Results: We have constructed 70 networks connecting SARS-CoV-2 viral proteins to various biological functions, diseases, and pathways reflecting viral biology, clinical observations, and co-morbidities in the context of COVID-19. Results are presented in the form of interactive network visualizations through a web interface, the Coronavirus Network Explorer (CNE), that allows exploration of underlying experimental evidence. We find that existing drugs targeting genes in those networks are strongly enriched in the set of drugs that are already in clinical trials against COVID-19. Conclusions: The approach presented here can identify biologically plausible hypotheses for COVID-19 pathogenesis, explicitly connected to the immunological, virological and pathological observations seen in SARS-CoV-2 infected patients. The discovery of repurposable drugs is driven by prior knowledge of relevant functional endpoints that reflect known viral biology or clinical observations, therefore suggesting potential mechanisms of action. We believe that the CNE offers relevant insights that go beyond more conventional network approaches, and can be a valuable tool for drug repurposing. The CNE is available at https://digitalinsights.qiagen.com/coronavirus-.network-.explorer.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] The structural basis of accelerated host cell entry by SARS-CoV-2†
    Seyran, Murat
    Takayama, Kazuo
    Uversky, Vladimir N.
    Lundstrom, Kenneth
    Palu, Giorgio
    Sherchan, Samendra P.
    Attrish, Diksha
    Rezaei, Nima
    Aljabali, Alaa A. A.
    Ghosh, Shinjini
    Pizzol, Damiano
    Chauhan, Gaurav
    Adadi, Parise
    Mohamed Abd El-Aziz, Tarek
    Soares, Antonio G.
    Kandimalla, Ramesh
    Tambuwala, Murtaza
    Hassan, Sk. Sarif
    Azad, Gajendra Kumar
    Pal Choudhury, Pabitra
    Baetas-da-Cruz, Wagner
    Serrano-Aroca, Angel
    Brufsky, Adam M.
    Uhal, Bruce D.
    [J]. FEBS JOURNAL, 2021, 288 (17) : 5010 - 5020
  • [22] Large-Scale Screening of CD4+ T-Cell Epitopes From SARS-CoV-2 Proteins and the Universal Detection of SARS-CoV-2 Specific T Cells for Northeast Asian Population
    Zhao, Yu
    He, Chengtao
    Peng, Min
    Li, Min
    Liu, Xiaotao
    Han, Xuelian
    Fu, Qiang
    Wu, Yandan
    Yue, Fangping
    Yan, Chunguang
    Zhao, Guangyu
    Shen, Chuanlai
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2025, 97 (02)
  • [23] Genetic Analysis of the Coronavirus SARS-CoV-2 Host Protease TMPRSS2 in Different Populations
    Russo, Roberta
    Andolfo, Immacolata
    Lasorsa, Vito Alessandro
    Iolascon, Achille
    Capasso, Mario
    [J]. FRONTIERS IN GENETICS, 2020, 11
  • [24] Factors Affecting SARS-CoV-2 IgG Production after Vaccination and/or Disease: A Large-Scale Seroprevalence Study
    Karl, Tanja
    Schuster, Anja
    Stangassinger, Lea Maria
    Stiboller, Tanja
    Cadamuro, Janne
    Oostingh, Gertie Janneke
    [J]. VACCINES, 2023, 11 (10)
  • [25] UMAP-assisted K-means clustering of large-scale SARS-CoV-2 mutation datasets
    Hozumi, Yuta
    Wang, Rui
    Yin, Changchuan
    Wei, Guo-Wei
    [J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 131
  • [26] Assessment of the Effective Sensitivity of SARS-CoV-2 SamplePooling Based on a Large-Scale Screening Experience:Retrospective Analysis
    Alvargonzalez, Jorge J. Cabrera
    Larranaga, Ana
    Martinez, Javier
    Castro, Sonia Perez
    Cao, Sonia Rey
    Nunez, Carlos Davina
    Perez, Victor Del Campo
    Parrondo, Carmen Duran
    Luque, Silvia Suarez
    Alonso, Elena Gonzalez
    Tojo, Alfredo JoseSilva
    Porteiro, Jacobo
    Regueiro, Benito
    [J]. JMIR PUBLIC HEALTH AND SURVEILLANCE, 2024, 10 : e54503
  • [27] Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications
    Altincekic, Nadide
    Korn, Sophie Marianne
    Qureshi, Nusrat Shahin
    Dujardin, Marie
    Ninot-Pedrosa, Marti
    Abele, Rupert
    Saad, Marie Jose Abi
    Alfano, Caterina
    Almeida, Fabio C. L.
    Alshamleh, Islam
    de Amorim, Gisele Cardoso
    Anderson, Thomas K.
    Anobom, Cristiane D.
    Anorma, Chelsea
    Bains, Jasleen Kaur
    Bax, Adriaan
    Blackledge, Martin
    Blechar, Julius
    Bockmann, Anja
    Brigandat, Louis
    Bula, Anna
    Buetikofer, Matthias
    Camacho-Zarco, Aldo R.
    Carlomagno, Teresa
    Caruso, Icaro Putinhon
    Ceylan, Betul
    Chaikuad, Apirat
    Chu, Feixia
    Cole, Laura
    Crosby, Marquise G.
    de Jesus, Vanessa
    Dhamotharan, Karthikeyan
    Felli, Isabella C.
    Ferner, Jan
    Fleischmann, Yanick
    Fogeron, Marie-Laure
    Fourkiotis, Nikolaos K.
    Fuks, Christin
    Fuertig, Boris
    Gallo, Angelo
    Gande, Santosh L.
    Gerez, Juan Atilio
    Ghosh, Dhiman
    Gomes-Neto, Francisco
    Gorbatyuk, Oksana
    Guseva, Serafima
    Hacker, Carolin
    Haefner, Sabine
    Hao, Bing
    Hargittay, Bruno
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [28] Impact of a large-scale event on SARS-CoV-2 cases and hospitalizations in the Netherlands, carnival seasons 2022 and 2023
    Gorgels, Koen M. F.
    Dukers-Muijrers, Nicole H. T. M.
    Evers, Ymke J.
    Hackert, Volker H.
    Savelkoul, Paul H. M.
    Hoebe, Christian J. P. A.
    [J]. PUBLIC HEALTH IN PRACTICE, 2024, 8
  • [29] Analytical Validation and Clinical Application of Rapid Serological Tests for SARS-CoV-2 Suitable for Large-Scale Screening
    De Nicolo, Amedeo
    Avataneo, Valeria
    Cusato, Jessica
    Palermiti, Alice
    Mula, Jacopo
    De Vivo, Elisa
    Antonucci, Miriam
    Bonora, Stefano
    Calcagno, Andrea
    Di Perri, Giovanni
    De Rosa, Francesco Giuseppe
    D'Avolio, Antonio
    [J]. DIAGNOSTICS, 2021, 11 (05)
  • [30] Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
    Yuan, Tom Z.
    Garg, Pankaj
    Wang, Linya
    Willis, Jordan R.
    Kwan, Eric
    Hernandez, Ana G. Lujan
    Tuscano, Emily
    Sever, Emily N.
    Keane, Erica
    Soto, Cinque
    Mucker, Eric M.
    Fouch, Mallorie E.
    Davidson, Edgar
    Doranz, Benjamin J.
    Kailasan, Shweta
    Aman, M. Javad
    Li, Haoyang
    Hooper, Jay W.
    Saphire, Erica Ollmann
    Crowe, James E.
    Liu, Qiang
    Axelrod, Fumiko
    Sato, Aaron K.
    [J]. MABS, 2022, 14 (01)